ArticleClinical journal of the American Society of Nephrology : CJASN2013
Cumulative patency of contemporary fistulas versus grafts (2000-2010).
Article in Clinical journal of the American Society of Nephrology : CJASN, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
76 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- UK Kidney Association Clinical Practice Guideline on vascular access for haemodialysis.BMC nephrology · 2025Guideline
- Pooled it
- Complications of the Arteriovenous Fistula: A Systematic Review.Journal of the American Society of Nephrology : JASN · 2017Pooled it
- The vascular access in the elderly: a position statement of the Vascular Access Working Group of the Italian Society of Nephrology.Journal of nephrology · 2016Guideline
- Trial
- Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials.Lancet (London, England) · 2016Trial
- Comparative outcomes of arteriovenous accesses with and without tunneled hemodialysis catheters: A retrospective cohort study.Medicine · 2026Article
- Optimizing Dialysis Vascular Access: Moving beyond Fistula First.Clinical journal of the American Society of Nephrology : CJASN · 2026Review
- Development of a prediction model to estimate short- and long-term clinical outcomes in arteriovenous grafts for hemodialysis patients.European journal of medical research · 2025Article
- Incidence and Risk Factors of Primary Arteriovenous Access Failure in Dialysis Patients: A National-Based Retrospective Cohort Study.Health science reports · 2025Article
- Anatomy of Endovascular Arteriovenous Fistula Creation.Seminars in interventional radiology · 2025Review
- Article
- Sirolimus-coated balloon angioplasty in maintaining the patency of thrombosed arteriovenous graft: 1-year results of a prospective study.The journal of vascular access · 2024Article
- Patients, healthcare providers, and general population preferences for hemodialysis vascular access: a discrete choice experiment.Frontiers in public health · 2024Article
- The reasons for comparative effectiveness clinical trials of arteriovenous fistula versus graft strategy in older adults on hemodialysis with a catheter.Clinical nephrology · 2023Article
- Functional patency rates of arteriovenous fistula of a retrospective cohort study from one of the biggest centers in Canada.International urology and nephrology · 2023Article
- Article
- Placing an appropriate tunneled dialysis catheter in an appropriate patient including the nonconventional sites.Cardiovascular diagnosis and therapy · 2023Review
- Surgical creation of lower extremity fistula and grafts.Cardiovascular diagnosis and therapy · 2023Review
- The challenging surgical vascular access creation.Cardiovascular diagnosis and therapy · 2023Review
16 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesComparisons of fistulas and grafts often overlook the high primary failure rate of fistulas. This study compared cumulative patency (time from access creation to permanent failure) of fistulas and grafts. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Vascular accesses of 1140 hemodialysis patients from two centers (Toronto and London, Ontario, Canada, 2000-2010) were analyzed. Cumulative patency was compared between groups using Kaplan-Meier survival curves and log-rank tests. Hazard ratios (HRs) for fistula failure relative to grafts and 95% confidence intervals (95% CIs) are reported.
resultsThere were 1012 (88.8%) fistulas and 128 (11.2%) grafts. The primary failure rate was two times greater for fistulas than for grafts: 40% versus 19% (P<0.001). Cumulative patency did not differ between fistulas and grafts for the patients' first access (median, 7.4 versus 15.0 months, respectively [HR, 0.99; 95% CI, 0.79-1.23; P=0.85]) or for 600 with a subsequent access (7.0 versus 9.0 months [HR, 0.93; 95% CI, 0.77-1.13; P=0.39]). However, when primary failures were excluded, cumulative patency became significantly longer for fistulas than for grafts for both first and subsequent accesses (61.9 versus 23.8 months [HR, 0.56; 95% CI, 0.43-0.74; P<0.001] and 42.8 versus 15.9 months [HR, 0.56; 95% CI, 0.44-0.72; P<0.001]). Results were similar for forearm and upper-arm accesses. Compared with functioning fistulas, grafts necessitated twice as many angioplasties (1.4 versus 3.2/1000 days, respectively; P<0.001) and significantly more thrombolysis interventions (0.06 versus 0.98/1000 days; P<0.001) to maintain patency once matured and successfully used for dialysis.
conclusionsCumulative patency did not differ between fistulas and grafts; however, grafts necessitated more interventions to maintain functional patency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.